Mechanisms Involved in T cell trafficking in GVHD
GVHD 中 T 细胞运输的机制
基本信息
- 批准号:7262420
- 负责人:
- 金额:$ 30.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAllogenicAnimalsAntigensApoptosisAreaBindingBiologyCCL3 geneCCL4 geneCCR1 geneCCR5 geneCCR9 geneCD4 Positive T LymphocytesCD8B1 geneCell physiologyCell-Mediated CytolysisCellsChemokine (C-C Motif) Receptor 5ClassDiseaseExtravasationFunctional disorderGPR2 geneGastrointestinal tract structureGeneticGoalsImmigrationIncidenceInflammationIntegrinsKnockout MiceLeukocytesLigandsLiverLungMHC Class I GenesMHC Class II GenesMajor Histocompatibility ComplexMalignant - descriptorMediatingMethodsMinorModelingMonoclonal AntibodiesMononuclear LeukocytesNumbersOrganPathway interactionsPeptidesPhase I Clinical TrialsPlayPreventionProductionProtein FamilyProteinsQualifyingReceptor SignalingRecruitment ActivityRoleSeveritiesSignaling ProteinSiteSkinStem cell transplantSurfaceT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTissuesTransplantationVascular Endothelial CellWorkbasebeta-Chemokineschemokinechemokine receptorgraft versus host disease inductiongraft vs host diseaseinhibitor/antagonistmigrationpeptidomimeticspreventreceptorresearch studyresponsetrafficking
项目摘要
DESCRIPTION (provided by applicant):
The limiting factor to allogeneic stem cell transplantation is the occurrence of GVHD, which is due to the recognition by alloreactive T lymphocytes of major and minor antigens presented by major histocompatibility complex proteins. GVHD occurs in a subset of organs and involves early migration of alloreactive T cells into these organs followed by T cell expansion and later tissue destruction. The proteins and mechanisms involved in the migration of alloreactive T cells into GVHD target organs is poorly understood. A greater understanding of this might allow for new forms of therapy for the treatment or prevention of GVHD. Our group has focused on the roles of chemokines, chemokine receptors and integrins in the migration of alloreactive T cells into the GI tract, liver, lung and skin. Our group was the first to show that a chemokine, CCL3, plays a role in the trafficking of CD8+ T cells into the liver and lung. We were also the first group to show that CCL3 blockade enhanced the expansion of CD4+ T cells in the liver and that the chemokine receptor CCR5 played a significant role in controlling the expansion and migration of both CD8+and CD4+ T cells into the liver and lung.
In this proposal, we will investigate the mechanisms involved in the trafficking and expansion of T cells in the liver and lung. We will use genetic and immunological methods to investigate the following specific aims:
1. The mechanism involved in the increased number of alloreactive CD4+ and CD8+ T cells in the liver and lung after the transfer of T cells that do not express CCR5.
2. We will evaluate the hypothesis that trafficking of T cells into GVHD target organs uses different chemokine receptors for entrance into the specific organs. Specifically, we will investigate the functions of CCR1, CCR9 and CCR10 in the trafficking of T cells into the liver, GI tract and skin respectively.
3. We will investigate the function of CCR5 on recipient APCs in the induction of GVHD
4. We will evaluate if small peptides that could be used clinically are effective in blocking the occurrence of GVHD as a prelude to their use in phase I clinical trials.
描述(由申请人提供):
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bacterial sepsis and GI tract GVHD: more commensal than you think.
细菌性败血症和胃肠道 GVHD:比您想象的更共生。
- DOI:10.1182/blood-2012-05-427435
- 发表时间:2012
- 期刊:
- 影响因子:20.3
- 作者:Serody,Jonathan
- 通讯作者:Serody,Jonathan
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan S. Serody其他文献
Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease
- DOI:
10.1016/j.bbmt.2014.11.494 - 发表时间:
2015-02-01 - 期刊:
- 影响因子:
- 作者:
Thomas C. Shea;Christine M. Walko;Yunro Chung;Anastasia Ivanova;Kamakshi V. Rao;James Coghill;Stefanie Sarantopoulos;William A. Wood;Paul Armistead;Don A. Gabriel;Jonathan S. Serody - 通讯作者:
Jonathan S. Serody
The Composition of Acute Myeloid Leukemia Cell Differentiation States Predicts Response to Immune Checkpoint Blockade
急性髓系白血病细胞分化状态的组成预测免疫检查点阻断的反应
- DOI:
10.1182/blood-2022-165458 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:23.100
- 作者:
Joseph Rimando;Leslie Cope;Karen McKinnon;Benjamin G. Vincent;Sergio Rutella;Joshua F. Zeidner;Jonathan S. Serody;Ivana Gojo;Leo Luznik - 通讯作者:
Leo Luznik
Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma
- DOI:
10.1182/blood-2022-156660 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Timothy J. Voorhees;Anne W. Beaven;Christopher Dittus;George E Hucks;J. Kaitlin Morrison;Catherine Joyce Arago Cheng;Tammy Cavallo;Steven I. Park;Gianpietro Dotti;Jonathan S. Serody;Barbara Savoldo;Natalie S. Grover - 通讯作者:
Natalie S. Grover
Alternative tumour-specific antigens
肿瘤特异性替代抗原
- DOI:
10.1038/s41568-019-0162-4 - 发表时间:
2019-07-05 - 期刊:
- 影响因子:66.800
- 作者:
Christof C. Smith;Sara R. Selitsky;Shengjie Chai;Paul M. Armistead;Benjamin G. Vincent;Jonathan S. Serody - 通讯作者:
Jonathan S. Serody
<em>Characterization of a Cyclic Dinucleotide Metabolic Switch to Fuel Antitumor Immunity</em>
- DOI:
10.1182/blood-2022-169006 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Jeremy A. Meier;Katie E. Hurst;David L. Corcoran;Jessica E. Thaxton;Jonathan S. Serody - 通讯作者:
Jonathan S. Serody
Jonathan S. Serody的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan S. Serody', 18)}}的其他基金
UNC Immunotherapy Training Grant (IM-TAG)
北卡罗来纳大学免疫治疗培训补助金 (IM-TAG)
- 批准号:
10767617 - 财政年份:2023
- 资助金额:
$ 30.69万 - 项目类别:
SToP Cancer SPORE: Career Enhancement Program
STOP Cancer SPORE:职业提升计划
- 批准号:
10334089 - 财政年份:2022
- 资助金额:
$ 30.69万 - 项目类别:
SToP Cancer SPORE: Career Enhancement Program
STOP Cancer SPORE:职业提升计划
- 批准号:
10705618 - 财政年份:2022
- 资助金额:
$ 30.69万 - 项目类别:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
增强同种异体 HSCT 后的先天免疫重建。
- 批准号:
10297917 - 财政年份:2021
- 资助金额:
$ 30.69万 - 项目类别:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
增强同种异体 HSCT 后的先天免疫重建。
- 批准号:
10653130 - 财政年份:2021
- 资助金额:
$ 30.69万 - 项目类别:
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
增强同种异体 HSCT 后的先天免疫重建。
- 批准号:
10470834 - 财政年份:2021
- 资助金额:
$ 30.69万 - 项目类别:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
ILC2 细胞治疗/预防 GVHD 的机制评估
- 批准号:
9403099 - 财政年份:2017
- 资助金额:
$ 30.69万 - 项目类别:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
ILC2 细胞治疗/预防 GVHD 的机制评估
- 批准号:
9918441 - 财政年份:2017
- 资助金额:
$ 30.69万 - 项目类别:
Mechanistic Evaluations of ILC2 Cells for the Treatment/Prevention of GVHD
ILC2 细胞治疗/预防 GVHD 的机制评估
- 批准号:
9528655 - 财政年份:2017
- 资助金额:
$ 30.69万 - 项目类别:
Th1/Th17 Macrophage Interactions in Cutaneous GVHD
皮肤 GVHD 中 Th1/Th17 巨噬细胞的相互作用
- 批准号:
9024463 - 财政年份:2012
- 资助金额:
$ 30.69万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 30.69万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 30.69万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 30.69万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 30.69万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 30.69万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 30.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 30.69万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 30.69万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 30.69万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 30.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




